Abstract
Serum light-chain neurofilaments (sNfL) have been investigated as a potential minimally invasive biomarker that could help in the diagnosis of patients with cognitive symptoms. We assessed the correlation between sNfL and cerebrospinal fluid (CSF) biomarkers (sNfL versus CSF NfL, ρ= 0.70, p < 0.001), the performance of sNfL in distinguishing controls from patients (controls versus frontotemporal dementia, area under curve 0.86), and sNfL differences in mild cognitive impairment according to amyloid-β (Aβ) deposition (Aβ versus non-Aβ, p = 0.017). Our results support the role of this biomarker in the screening and risk stratification of patients followed in a neurological consultation of a tertiary center.
Keywords
Get full access to this article
View all access options for this article.
References
1.
Ashton
NJ
,
Hye
A
,
Rajkumar
AP
,
Leuzy
A
,
Snowden
S
,
Suárez-Calvet
M
,
Karikari
TK
,
Schöll
M
,
la Joie
R
,
Rabinovici
GD
,
Höglund
K
,
Ballard
C
,
Hortobágyi
T
,
Svenningsson
P
,
Blennow
K
,
Zetterberg
H
,
Aarsland
D
(2020 ) An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders . Nat Rev Neurol 16 , 265 –284 .
2.
Li
D
,
Mielke
MM
(2019 ) An update on blood-based markers of Alzheimer’s disease using the SiMoA platform . Neurol Ther 8 , 73 –82 .
3.
Dubois
B
,
Feldman
HH
,
Jacova
C
,
Hampel
H
,
Molinuevo
JL
,
Blennow
K
,
Dekosky
ST
,
Gauthier
S
,
Selkoe
D
,
Bateman
R
,
Cappa
S
,
Crutch
S
,
Engelborghs
S
,
Frisoni
GB
,
Fox
NC
,
Galasko
D
,
Habert
MO
,
Jicha
GA
,
Nordberg
A
,
Pasquier
F
,
Rabinovici
G
,
Robert
P
,
Rowe
C
,
Salloway
S
,
Sarazin
M
,
Epelbaum
S
,
de Souza
LC
,
Vellas
B
,
Visser
PJ
,
Schneider
L
,
Stern
Y
,
Scheltens
P
,
Cummings
JL
(2014 ) Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria . Lancet Neurol 13 , 614 –629 .
4.
Jack
CR
,
Bennett
DA
,
Blennow
K
,
Carrillo
MC
,
Dunn
B
,
Haeberlein
SB
,
Holtzman
DM
,
Jagust
W
,
Jessen
F
,
Karlawish
J
,
Liu
E
,
Molinuevo
JL
,
Montine
T
,
Phelps
C
,
Rankin
KP
,
Rowe
CC
,
Scheltens
P
,
Siemers
E
,
Snyder
HM
,
Sperling
R
,
Elliott
C
,
Masliah
E
,
Ryan
L
,
Silverberg
N
(2018 ) NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease . Alzheimers Dement 14 , 535 –562 .
5.
Leuzy
A
,
Mattsson-Carlgren
N
,
Palmqvist
S
,
Janelidze
S
,
Dage
JL
,
Hansson
O
(2022 ) Blood-based biomarkers for Alzheimer’s disease , EMBO Mol Med 14 , e14408 .
6.
Zhao
Y
,
Xin
Y
,
Meng
S
,
He
Z
,
Hu
W
(2019 ) Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis . Neurosci Biobehav Rev 102 , 123 –138 .
7.
Steinacker
P
,
Anderl-Straub
S
,
Diehl-Schmid
J
,
Semler
E
,
Uttner
I
,
Von Arnim
CAF
,
Barthel
H
,
Danek
A
,
Fassbender
K
,
Fliessbach
K
,
Foerstl
H
,
Grimmer
T
,
Huppertz
HJ
,
Jahn
H
,
Kassubek
J
,
Kornhuber
J
,
Landwehrmeyer
B
,
Lauer
M
,
Maler
JM
,
Mayer
B
,
Oeckl
P
,
Prudlo
J
,
Schneider
A
,
Volk
AE
,
Wiltfang
J
,
Schroeter
ML
,
Ludolph
AC
,
Otto
M
(2018 ) Serum neurofilament light chain in behavioral variant frontotemporal dementia , Neurology 91 , E1390 –E1401 .
8.
Illán-Gala
I
,
Lleo
A
,
Karydas
A
,
Staffaroni
AM
,
Zetterberg
H
,
Sivasankaran
R
,
Grinberg
LT
,
Spina
S
,
Kramer
JH
,
Ramos
EM
,
Coppola
G
,
la Joie
R
,
Rabinovici
GD
,
Perry
DC
,
Gorno-Tempini
ML
,
Seeley
WW
,
Miller
BL
,
Rosen
HJ
,
Blennow
K
,
Boxer
AL
,
Rojas
JC
(2021 ) Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease , Neurology 96 , e671 –e683 .
9.
Silva-Spínola
A
,
Lima
M
,
Leitão
MJ
,
Durães
J
,
Tábuas-Pereira
M
,
Almeida
MR
,
Santana
I
,
Baldeiras
I
(2022 ) Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia . Eur J Neurol 29 , 36 –46 .
10.
Preische
O
,
Schultz
SA
,
Apel
A
,
Kuhle
J
,
Kaeser
SA
,
Barro
C
,
Gräber
S
,
Kuder-Buletta
E
,
LaFougere
C
,
Laske
C
,
Vöglein
J
,
Levin
J
,
Masters
C
,
Martins
R
,
Schofield
P
,
Rossor
MN
,
Graff-Radford
N
,
Salloway
S
,
Ghetti
B
,
Ringman
J
,
Noble
J
,
Chhatwal
J
,
Goate
A
,
Benzinger
T
,
Morris
J
,
Bateman
R
,
Wang
G
,
Fagan
A
,
McDade
E
,
Gordon
B
,
Jucker
M
,
Allegri
R
,
Amtashar
F
,
Berman
S
,
Bodge
C
,
Brandon
S
,
Brooks
W
,
Buck
J
,
Buckles
V
,
Chea
S
,
Chrem
P
,
Chui
H
,
Cinco
J
,
Clifford
J
,
Cruchaga
C
,
D’Mello
M
,
Donahue
T
,
Douglas
J
,
Edigo
N
,
Erekin-Taner
N
,
Farlow
M
,
Farrar
A
,
Feldman
H
,
Flynn
G
,
Fox
N
,
Franklin
E
,
Fujii
H
,
Gant
C
,
Gardener
S
,
Goldman
J
,
Gray
J
,
Gurney
J
,
Hassenstab
J
,
Hirohara
M
,
Holtzman
D
,
Hornbeck
R
,
DiBari
SH
,
Ikeuchi
T
,
Ikonomovic
S
,
Jerome
G
,
Karch
C
,
Kasuga
K
,
Kawarabayashi
T
,
Klunk
W
,
Koeppe
R
,
Lee
JH
,
Marcus
D
,
Mason
NS
,
Maue-Dreyfus
D
,
Montoya
L
,
Mori
H
,
Nagamatsu
A
,
Neimeyer
K
,
Norton
J
,
Perrin
R
,
Raichle
M
,
Roh
JH
,
Shimada
H
,
Shiroto
T
,
Shoji
M
,
Sigurdson
W
,
Sohrabi
H
,
Sparks
P
,
Suzuki
K
,
Swisher
L
,
Taddei
K
,
Wang
J
,
Wang
P
,
Weiner
M
,
Wolfsberger
M
,
Xiong
C
,
Xu
X
(2019 ) Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease . Nat Med 25 , 277 –283 .
11.
Rauchmann
BS
,
Schneider-Axmann
T
,
Perneczky
R
(2021 ) Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition . J Neurol Neurosurg Psychiatry 92 , 1289 –1295 .
12.
Ashton
NJ
,
Janelidze
S
,
al Khleifat
A
,
Leuzy
A
,
van der Ende
EL
,
Karikari
TK
,
Benedet
AL
,
Pascoal
TA
,
Lleó
A
,
Parnetti
L
,
Galimberti
D
,
Bonanni
L
,
Pilotto
A
,
Padovani
A
,
Lycke
J
,
Novakova
L
,
Axelsson
M
,
Velayudhan
L
,
Rabinovici
GD
,
Miller
B
,
Pariante
C
,
Nikkheslat
N
,
Resnick
SM
,
Thambisetty
M
,
Schöll
M
,
Fernández-Eulate
G
,
Gil-Bea
FJ
,
López
de Munain A
,
Al-Chalabi
A
,
Rosa-Neto
P
,
Strydom
A
,
Svenningsson
P
,
Stomrud
E
,
Santillo
A
,
Aarsland
D
,
van Swieten
JC
,
Palmqvist
S
,
Zetterberg
H
,
Blennow
K
,
Hye
A
,
Hansson
O
(2021 ) A multicentre validation study of the diagnostic value of plasma neurofilament light . Nat Commun 12 , 3400 .
13.
Rascovsky
K
,
Hodges
JR
,
Knopman
D
,
Mendez
MF
,
Kramer
JH
,
Neuhaus
J
,
Van Swieten
JC
,
Seelaar
H
,
Dopper
EGP
,
Onyike
CU
,
Hillis
AE
,
Josephs
KA
,
Boeve
BF
,
Kertesz
A
,
Seeley
WW
,
Rankin
KP
,
Johnson
JK
,
Gorno-Tempini
ML
,
Rosen
H
,
Prioleau-Latham
CE
,
Lee
A
,
Kipps
CM
,
Lillo
P
,
Piguet
O
,
Rohrer
JD
,
Rossor
MN
,
Warren
JD
,
Fox
NC
,
Galasko
D
,
Salmon
DP
,
Black
SE
,
Mesulam
M
,
Weintraub
S
,
Dickerson
BC
,
Diehl-Schmid
J
,
Pasquier
F
,
Deramecourt
V
,
Lebert
F
,
Pijnenburg
Y
,
Chow
TW
,
Manes
F
,
Grafman
J
,
Cappa
SF
,
Freedman
M
,
Grossman
M
,
Miller
BL
(2011 ) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia . Brain 134 , 2456 –2477 .
14.
Gorno-Tempini
ML
,
Hillis
AE
,
Weintraub
S
,
Kertesz
A
,
Mendez
M
,
Cappa
SF
,
Ogar
JM
,
Rohrer
JD
,
Black
S
,
Boeve
BF
,
Manes
F
,
Dronkers
NF
,
Vandenberghe
R
,
Rascovsky
K
,
Patterson
K
,
Miller
BL
,
Knopman
DS
,
Hodges
JR
,
Mesulam
MM
,
Grossman
M
(2011 ) Classification of primary progressive aphasia and its variants . Neurology 76 , 1006 –1014 .
15.
McKhann
GM
,
Knopman
DS
,
Chertkow
H
,
Hyman
BT
,
Jack
CR
,
Kawas
CH
,
Klunk
WE
,
Koroshetz
WJ
,
Manly
JJ
,
Mayeux
R
,
Mohs
RC
,
Morris
JC
,
Rossor
MN
,
Scheltens
P
,
Carrillo
MC
,
Thies
B
,
Weintraub
S
,
Phelps
CH
(2011 ) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease . Alzheimers Dement 7 , 263 –269 .
16.American Psychiatric Association (2013 ) Mild Neurocognitive Disorder . In Diagnostic and statistical manual of mental disorders (5th ed. ).
17.
Rissin
DM
,
Kan
CW
,
Campbell
TG
,
Howes
SC
,
Fournier
DR
,
Song
L
,
Piech
T
,
Patel
PP
,
Chang
L
,
Rivnak
AJ
,
Ferrell
EP
,
Randall
JD
,
Provuncher
GK
,
Walt
DR
,
Duffy
DC
(2010 ) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations . Nat Biotechnol 28 , 595 –599 .
18.
Mattsson
N
,
Andreasson
U
,
Zetterberg
H
,
Blennow
K
,
Weiner
MW
,
Aisen
P
,
Toga
AW
,
Petersen
R
,
Jack
CR
,
Jagust
W
,
et
al.
(2017 ) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease . JAMA Neurol 74 , 557 –566 .
19.
Jin
M
,
Cao
L
,
Dai
YP
(2019 ) Role of neurofilament light chain as a potential biomarker for Alzheimer’s disease: A correlative meta-analysis . Front Aging Neurosci 11 , 254 .
20.
Xiong
YL
,
Meng
T
,
Luo
J
,
Zhang
H
(2021 ) The potential of neurofilament light as a biomarker in Alzheimer’s disease . Eur Neurol 84 , 6 –15 .
21.
Liu
S
,
Huang
Z
,
Zhang
L
,
Pan
J
,
Lei
Q
,
Meng
Y
,
Li
Z
(2020 ) Plasma neurofilament light chain may be a biomarker for the inverse association between cancers and neurodegenerative diseases . Front Aging Neurosci 12 , 10 .
22.
Lee
EH
,
Kwon
HS
,
Koh
SH
,
Choi
SH
,
Jin
JH
,
Jeong
JH
,
Jang
JW
,
Park
KW
,
Kim
EJ
,
Kim
HJ
,
Hong
JY
,
Yoon
SJ
,
Yoon
B
,
Kang
JH
,
Lee
JM
,
Park
HH
,
Ha
J
(2022 ) Serum neurofilament light chain level as a predictor of cognitive stage transition . Alzheimers Res Ther 14 , 6 .
23.
Mattsson
N
,
Cullen
NC
,
Andreasson
U
,
Zetterberg
H
,
Blennow
K
(2019 ) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease . JAMA Neurol 76 , 791 –799 .
24.
Chouliaras
L
,
Thomas
A
,
Malpetti
M
,
Donaghy
P
,
Kane
J
,
Mak
E
,
Savulich
G
,
Prats-Sedano
MA
,
Heslegrave
AJ
,
Zetterberg
H
,
Su
L
,
Rowe
JB
,
O’Brien
JT
(2022 ) Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy . J Neurol Neurosurg Psychiatry 93 , 651 –658 .
25.
Karikari
TK
,
Ashton
NJ
,
Brinkmalm
G
,
Brum
WS
,
Benedet
AL
,
Montoliu-Gaya
L
,
Lantero-Rodriguez
J
,
Pascoal
TA
,
Suárez-Calvet
M
,
Rosa-Neto
P
,
Blennow
K
,
Zetterberg
H
(2022 ) Blood phospho-tau in Alzheimer disease: Analysis, interpretation, and clinical utility . Nat Rev Neurol 18 , 400 –418 .